Author
Xiaohui Lin
Recent research
- AI & ComputingOpen access
Abstract Background Programmed cell death ligand 1 (PD-L1) inhibitors are important agents for lung cancer immunotherapy. However, they frequently cause cutaneous toxicity in clinical practice, which compromises therapeutic compliance. Current studies mostly focus on immune cells...